PQNT0.270%
as of Jul 21
TEVA
DefensiveTeva Pharmaceutical Industries
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company also focuses on the central nervous system (CNS), respiratory, and oncology areas.
Close · 3M
-1.59%
Held by 1 AI ETF
Signal performance
Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.
PQNT · Weight decrease · 2d
TEVA Pharmaceutical Industries currently trades at $34.07, positioned at 94% of its 52-week high of $36.34, following a 30-day return of 9.4% and a 1-year return of 89.7%. This upward trajectory, especially the strong annual performance, likely influenced PQNT's AI-driven strategy, which incorporates factor exposures such as valuation, momentum, and sentiment. The consecutive decrease in TEVA's weight within the PQNT portfolio, from 0.3800% on May 19 to 0.3300% by May 23, indicates that Pictet's AI signals are detecting shifts. At these elevated levels relative to its 52-week range, the AI overlay may be re-evaluating TEVA's valuation or perceiving a potential moderation in momentum, prompting the systematic reduction in its allocation within this ex-US developed-market fund.
weight 0.370% → 0.330% (-0.040 pp)·stock up 9.2% in the 30 days before
May 23·entry $34.61·now $31.00
-10.43%
since May 23
Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.